GAIN THERAPEUTICS INC
GANX·36269B105·US·Common Stock·Healthcare - Biotechnology
GANX (GAIN THERAPEUTICS INC) is held by 32 institutional investors as of Q2 2026. Largest holders: MARSHALL WACE, LLP ($3.9M), JONES FINANCIAL COMPANIES LLLP ($1.1M), VANGUARD CAPITAL MANAGEMENT LLC ($974,946). Net institutional sentiment: Mixed.
32
Holders
$11M
Total Value
60% (30)
Consensus
18 buying - 12 selling
13F: Insider & Congress: Updated regularly
Who's Trading
Source dates: Price Aug 28, 2026 · Insiders none · Activists none · Congress none
No recent insider, activist, or congressional trades for GANX.
Top Holders
Checking access…
Showing 1-20 of 36
1 / 2
Continue exploring
Other Healthcare stocks held by institutions
403 holders · $856.6B
403 holders · $286.8B
388 holders · $148B
385 holders · $405.5B
384 holders · $95B
381 holders · $105.8B
378 holders · $226B
375 holders · $51.2B
373 holders · $296.3B
371 holders · $110.7B
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer